Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

PHASERX, INC. (PZRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/19/2018 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
02/02/2018 8-K Other Events
02/01/2018 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
02/01/2018 8-K Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhi...
Docs: "Asset Purchase Agreement, between PhaseRx, Inc. and Roivant Sciences GmbH"
01/24/2018 8-K Other Events
01/18/2018 8-K Other Events
01/10/2018 8-K Other Events
12/15/2017 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "PhaseRx Receives Decision from the Nasdaq Hearings Panel for Continued Listing of Shares"
11/28/2017 8-K Other Events, Financial Statements and Exhibits
Docs: "PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from European Medicines Agency"
11/09/2017 10-Q Quarterly Report for the period ended September 30, 2017
11/09/2017 8-K Quarterly results
Docs: "PhaseRx Reports Third Quarter 2017 Financial Results and Provides Corporate Update"
11/02/2017 GN Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results
10/31/2017 8-K Quarterly results
10/13/2017 8-K Quarterly results
09/26/2017 8-K Quarterly results
09/20/2017 8-K Quarterly results
09/08/2017 8-K Quarterly results
08/24/2017 8-K Quarterly results
08/10/2017 10-Q Quarterly Report for the period ended June 30, 2017
08/10/2017 8-K Quarterly results
Docs: "PhaseRx Reports Second Quarter 2017 Financial Results and Provides Corporate Update"
07/10/2017 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
07/05/2017 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
06/29/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2017 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/30/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/26/2017 8-K Form 8-K - Current report
05/12/2017 10-Q Quarterly Report for the period ended March 31, 2017
05/12/2017 8-K Form 8-K - Current report
04/13/2017 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy